Caris Life Sciences and ConcertAI Form Broad Partnership Creating Industry-Leading Molecular Oncology Research Platform to Accelerate Drug Development and Novel Research

The Combination of Comprehensive Genomic Profiling with Reference-standard Clinical Data Establishes an Unmatched Translational and Clinical Development Research Platform IRVING, Texas and CAMBRIDGE, Mass., Jan. 9, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular...

Foundation Medicine Launches FoundationOne®Tracker ctDNA Monitoring Assay for Research Use in Partnership with Natera

CAMBRIDGE, Mass. and AUSTIN, Texas, June 8, 2021 /PRNewswire/ — Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA), today announced the launch of the research use version of FoundationOne®Tracker, Foundation Medicine’s personalized circulating tumor DNA (ctDNA) monitoring assay. FoundationOne Tracker uniquely combines Foundation Medicine’s tissue-based comprehensive genomic profiling...